Integrated Gut and Liver Microphysiological Systems for Quantitative In Vitro Pharmacokinetic Studies
Name
12248_2017_Article_122.pdf
Size
3.69 MB
Format
Adobe PDF
Checksum (MD5)
79e19b90e03fe3d15839daff0f5f4053
Author(s)
Stokes, Cynthia L
Tsamandouras, Nikolaos
Chen, Wen Li
Edington, Collin D
Griffith, Linda G
Cirit, Murat
Date Issued
July 2017
Journal
AAPS Journal
Publisher
American Association of Pharmaceutical Scientists
Citation
Tsamandouras, Nikolaos et al. “Integrated Gut and Liver Microphysiological Systems for Quantitative In Vitro Pharmacokinetic Studies.” The AAPS Journal 19, 5 (July 2017): 1499–1512 © 2017 The Author(s)
Version
Final published version
Abstract
Investigation of the pharmacokinetics (PK) of a compound is of significant importance during the early stages of drug development, and therefore several in vitro systems are routinely employed for this purpose. However, the need for more physiologically realistic in vitro models has recently fueled the emerging field of tissue-engineered 3D cultures, also referred to as organs-on-chips, or microphysiological systems (MPSs). We have developed a novel fluidic platform that interconnects multiple MPSs, allowing PK studies in multi-organ in vitro systems along with the collection of high-content quantitative data. This platform was employed here to integrate a gut and a liver MPS together in continuous communication, and investigate simultaneously different PK processes taking place after oral drug administration in humans (e.g., intestinal permeability, hepatic metabolism). Measurement of tissue-specific phenotypic metrics indicated that gut and liver MPSs can be fluidically coupled with circulating common medium without compromising their functionality. The PK of diclofenac and hydrocortisone was investigated under different experimental perturbations, and results illustrate the robustness of this integrated system for quantitative PK studies. Mechanistic model-based analysis of the obtained data allowed the derivation of the intrinsic parameters (e.g., permeability, metabolic clearance) associated with the PK processes taking place in each MPS. Although these processes were not substantially affected by the gut-liver interaction, our results indicate that inter-MPS communication can have a modulating effect (hepatic metabolism upregulation). We envision that our integrative approach, which combines multi-cellular tissue models, multi-MPS platforms, and quantitative mechanistic modeling, will have broad applicability in pre-clinical drug development.
MIT Department
Massachusetts Institute of Technology. Department of Biological Engineering
Terms of Use
Creative Commons Attribution
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1208/s12248-017-0122-4
